{"name":"Sumitomo Pharma Co., Ltd.","slug":"sumitomo-pharma-co-ltd","ticker":"","exchange":"","domain":"sumitomo-pharma.co.jp","description":"","hq":"Chūō","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"DSP-5423P Placebo-to-Flex","genericName":"DSP-5423P Placebo-to-Flex","slug":"dsp-5423p-placebo-to-flex","indication":"Other","status":"phase_3"},{"name":"fH1 2 ug","genericName":"fH1 2 ug","slug":"fh1-2-ug","indication":"Other","status":"phase_1"},{"name":"DSP-0546LP 5 ug","genericName":"DSP-0546LP 5 ug","slug":"dsp-0546lp-5-ug","indication":"Other","status":"phase_1"},{"name":"DSP-3025","genericName":"DSP-3025","slug":"dsp-3025","indication":"Other","status":"phase_2"},{"name":"DSP-7888","genericName":"DSP-7888","slug":"dsp-7888","indication":"Other","status":"phase_2"},{"name":"DSP-9632P 27.5 mg","genericName":"DSP-9632P 27.5 mg","slug":"dsp-9632p-27-5-mg","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"DSP-5423P Active-to-Flex","genericName":"DSP-5423P Active-to-Flex","slug":"dsp-5423p-active-to-flex","indication":"Parkinson's disease (in development)","status":"phase_3"},{"name":"SM-13496 (lurasidone HCl)","genericName":"SM-13496 (lurasidone HCl)","slug":"sm-13496-lurasidone-hcl","indication":"Schizophrenia","status":"phase_3"},{"name":"ranirestat, (AS-3201)","genericName":"ranirestat, (AS-3201)","slug":"ranirestat-as-3201","indication":"Diabetic peripheral neuropathy","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Amrubicin hydrocloride","genericName":"Amrubicin hydrocloride","slug":"amrubicin-hydrocloride","indication":"Small cell lung cancer","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"SM-13496","genericName":"SM-13496","slug":"sm-13496","indication":"Treatment of type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"DSP-5423P Placebo-to-Flex","genericName":"DSP-5423P Placebo-to-Flex","slug":"dsp-5423p-placebo-to-flex","phase":"phase_3","mechanism":"DSP-5423P Placebo-to-Flex's mechanism of action is currently unknown.","indications":[],"catalyst":""},{"name":"fH1 2 ug","genericName":"fH1 2 ug","slug":"fh1-2-ug","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Amrubicin hydrocloride","genericName":"Amrubicin hydrocloride","slug":"amrubicin-hydrocloride","phase":"phase_3","mechanism":"Amrubicin is a topoisomerase II inhibitor that intercalates into DNA and prevents the religation of DNA strands, leading to cell death.","indications":["Small cell lung cancer","Non-small cell lung cancer"],"catalyst":""},{"name":"DSP-0546LP 5 ug","genericName":"DSP-0546LP 5 ug","slug":"dsp-0546lp-5-ug","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"DSP-3025","genericName":"DSP-3025","slug":"dsp-3025","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DSP-5423P Active-to-Flex","genericName":"DSP-5423P Active-to-Flex","slug":"dsp-5423p-active-to-flex","phase":"phase_3","mechanism":"DSP-5423P is a selective dopamine D1 receptor partial agonist designed to modulate dopaminergic signaling in the central nervous system.","indications":["Parkinson's disease (in development)"],"catalyst":""},{"name":"DSP-7888","genericName":"DSP-7888","slug":"dsp-7888","phase":"phase_2","mechanism":"DSP-7888 is a cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells.","indications":[],"catalyst":""},{"name":"DSP-9632P 27.5 mg","genericName":"DSP-9632P 27.5 mg","slug":"dsp-9632p-27-5-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SM-13496","genericName":"SM-13496","slug":"sm-13496","phase":"phase_3","mechanism":"SM-13496 is a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Treatment of type 2 diabetes"],"catalyst":""},{"name":"SM-13496 (lurasidone HCl)","genericName":"SM-13496 (lurasidone HCl)","slug":"sm-13496-lurasidone-hcl","phase":"phase_3","mechanism":"SM-13496 (lurasidone HCl) is an atypical antipsychotic that acts as a serotonin 2A receptor antagonist and a dopamine receptor antagonist.","indications":["Schizophrenia","Bipolar I disorder"],"catalyst":""},{"name":"ranirestat, (AS-3201)","genericName":"ranirestat, (AS-3201)","slug":"ranirestat-as-3201","phase":"phase_3","mechanism":"Ranirestat inhibits aldose reductase, the first enzyme in the polyol pathway, to reduce sorbitol accumulation and prevent diabetic complications.","indications":["Diabetic peripheral neuropathy","Diabetic complications (retinopathy, nephropathy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQb3BHQlZLeTk2OTdvLU5yaXoxdzJKdHphRHFmNnVtRDNuc2ZTMTlTbkJzSTVXUlNGMjE2d2tVY0VlSE0tWHhPTDE5YnZoSDdnNVNkYjhVbXJHVk15VjltbktkZ0RBZGlLNHFpS1dGUkFrY29mdlFMR3NxSFlreENHNEpFdklkMGJaejlKRTdueEEwdTlsZ3UzY1ZITzdlaDE4ZWozUnlSTXpBalk4OW92UzgxQQ?oc=5","date":"2026-04-08","type":"pipeline","source":"marketscreener.com","summary":"Sumitomo Pharma Co Ltd - Will conduct secondary share offering - marketscreener.com","headline":"Sumitomo Pharma Co Ltd - Will conduct secondary share offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQOXVvZ2VMZXc4MXNVSnEzM3dkb0lOdWJCemlHRk83cy10WWJKYTlZUURMOC1DMER3V1NoekxjTmZzTHlUUjctNXIzTUlnelU0UkdNc2NueWxnT18yLVdXU3VBM2hGY1lRMlhmX0dLMXNoQUR6WTJCcEQzbDZtMXhrOUdZQ01nekY1VzNBc01FME00WkRIYmtqRncwVWJ2VkY0Z0liM0VsM0lQTXZMdzZ1Sm42bmRBc0kyQlpMc0c1aHpyNGx0Wi1xV1F3?oc=5","date":"2026-04-08","type":"pipeline","source":"TradingView","summary":"Sumitomo Pharma Co Ltd - Will Conduct Secondary Share Offering - TradingView","headline":"Sumitomo Pharma Co Ltd - Will Conduct Secondary Share Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOTFJWR3Q5NlV6VGlOZ1ZZRmJlczR4cExXakIyQjRYT19QcHpuOUl3d2VTNlZWTzZFZGFybmVoTHhwY012Wm9kbUFEdmNRMHNtaG1nZFlBOGhvdzZtR21RakRUMEI4V191VEtKWUNnZGtyUDRxLUM5bVpGUEtMcHYwRHEwTXJEejFPSTNzMUNHQWxoYm5JYS1yVWVSanIzV1I2aGU3T2V0VUxTTjJ0RUI1OUhrbHVTTURoYVFRV0NlT25xYUl4?oc=5","date":"2026-04-08","type":"pipeline","source":"TipRanks","summary":"Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base - TipRanks","headline":"Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOZ2cwV2R0YVB0QWtmczhTLWtzNXE0dVRYLUE0NzdTVWd2dmt2Q085YUNCb0JtaXN5N2ZjZ1diSk4tZmYtOE9TVFFDUVA0OTZsRU1PNTRZTVNtc210T3B5Sm1namthaEdMb2tzUWRIOUQ5ZWwxQ3hweWpsZHNtWXgzSXVsZTZIY25BbVNqVnJFX3lBLTNRb3lIRE52R0hfS1B0aHdNUVJTUXF0RENJOHF2NWlzdGZNSXoweU1UcS0tUmFDQVZPNlBiN1lR?oc=5","date":"2026-04-08","type":"pipeline","source":"marketscreener.com","summary":"Sumitomo Pharma Co Ltd - To refinance existing borrowings through a bridge loan - marketscreener.com","headline":"Sumitomo Pharma Co Ltd - To refinance existing borrowings through a bridge loan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQX04tOTRucmdKaW5tX0tOc3JZQUh3ZmJrYXFUTlltS2diWDVTRXM5MTVQNzFmWXpDY0RUS2NHQi1fTjlmelhNajRsdklZdWxCYkpOTm5famlZYzBLVGxzTXNLQ3kyM3EzcEJxbXFaRmVWOUdNSGpsNFJzUzQ5S0taNVZfcllKc1ZFWWlfV1ZVbGxiS0RmYWphNEowV3pNX2tVMWJtbGdBa1ktLWhZWlI0cEE4Ym0wQQ?oc=5","date":"2026-04-08","type":"pipeline","source":"TipRanks","summary":"Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan - TipRanks","headline":"Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE0xUzFsbkg0c0N0OXQxVEZGZEdsT2dyd0JyZnZFYS03eGlULVJSWTItOXZHOGNYaG1LX1hzZ2tXbWpCbmQzeUJ3OUxFTVRldExKckRpYThfdDV2LUo5WlHSAWNBVV95cUxQNWhBamlHSlVvaW8tc1VFV1pMejh4eURQMjl1WkRKX0U1T2ZsNUlnNlNFR2FELWlydm9oeW1ucm5JcTlFdmxHNWVxRzVnTHBCSHRVTG05MkxpTzNjb3JJZFJCNjQ?oc=5","date":"2026-04-07","type":"pipeline","source":"Bitget","summary":"Sumitomo Pharma's Revised Outlook Creates Opportunity for Significant Revaluation - Bitget","headline":"Sumitomo Pharma's Revised Outlook Creates Opportunity for Significant Revaluation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOWHp0LVliWU1tLXM2bGRVcEtFcWl0VkFTdzVBSk9hTWdGZnE2OTFqQ1Qwb0JlZnhIaUl1MDVSdWRNc2o2RS1hd25Lc2JlUDRIbV81ZkZic3NkREdlU0g2U0VsVEtPQ0p3bU9xVXh1RmdxaVdYYk11a3VEXzQyNlBIMjhLUHduNmxNdGV1NlpCa19uZw?oc=5","date":"2026-04-06","type":"earnings","source":"Yahoo Finance","summary":"Sumitomo Pharma Co. Ltd. R (DPM.HM) Q4 FY2025 earnings call transcript - Yahoo Finance","headline":"Sumitomo Pharma Co. Ltd. R (DPM.HM) Q4 FY2025 earnings call transcript","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPbjlUcFV3bzdyUEtKTEdXLU9hZmtUODVnblpEeEVWREhWSFhwZWlkNkl6YkE3SUgzdkZqNV8xR2pHN3Bfb3VCQ1lXbGNhM3NNQzFlT1BiamgwdEdzVlZ5STZZU0VMUXFzX2pXdmp6aGlSOUIyNzlpM0VlMEgwZUx3MnlIQUhqNTcxYzV0cERKcEpFZ2cybG5LVDZJX1g0bVJ3T3FWSGE1Z185UHJ1dDA1SFRzalpFZw?oc=5","date":"2026-04-02","type":"pipeline","source":"Moomoo","summary":"Sumitomo Pharma experienced a significant drop due to heightened concerns over U.S. tariffs on pharmaceuticals. - Moomoo","headline":"Sumitomo Pharma experienced a significant drop due to heightened concerns over U.S. tariffs on pharmaceuticals.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOY2lWdkx6TEpmYnJIVUdJOERZaDl4RGRESFhKRWdqRVFUZjJWLUJ6QjA0clJtZ1FDbDhYa0RfZTBndWdBcEdEdHJxRkF6d1dmTThjLXNSOE9vdTVTTUZVMGV1YkpDY3FEb3BKME55clM2ZDlaSjVTSmdmSWZnTkRwSnNfbl9XOXE2V0lYeGd2UmowNVZTOU1sRTBWRVhDdGp3VmNxcy00NzhONlJFbmZZdEgxVWQ?oc=5","date":"2026-04-02","type":"pipeline","source":"富途牛牛","summary":"Sumitomo Pharma experienced a significant drop due to heightened concerns over U.S. tariffs on pharmaceuticals. - 富途牛牛","headline":"Sumitomo Pharma experienced a significant drop due to heightened concerns over U.S. tariffs on pharmaceuticals. - 富途牛牛","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPTnVGZVVjeUVRNzloNnQ5M2poZnE0dUtqMHBlN3Y0eHlZSG5RdUVMVHhsYmZNQkRkSDBENThZcFZZbThBbjhrcDc0NjBsZl9UR2pzN2FMdlJMYmtUSS1sV0dQRThHYlhpMlJWSy1NejZWbEp3aE9yNTgxaDFkMVhubGUwcEtkcGZLM2d3VjNfT1Z1RnJranFmLTlxVjhZZHZpUGtLd0ttNEFWbHNGUjhoaE1IVW8wLVBTNTJJMDZpR01waDlxMVk1MTdCdHVxamVq?oc=5","date":"2026-02-20","type":"pipeline","source":"Seeking Alpha","summary":"Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment - Seeking Alpha","headline":"Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOekExOVpFM1BwQ2ZFbDV4MVc3d3JxN2dwVHppQjNBbXhjUy1yeWlHaVk2UDdZVzc1MmtHS1BkVno0MXZuVDRxWmd4N0lrb3FZMG91NFJYU3FnXzE1VUFzUWhwcDZGV3NYSzJ0TFowbEotU3MtQ2hiZHJmcHBwT09Db2l1QXpENkY5ellXUEJkdmxGY0RLMmprZ2JORkw2b0RIRWI3Wi12MFU?oc=5","date":"2026-02-19","type":"pipeline","source":"Bloomberg.com","summary":"Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com","headline":"Sumitomo Pharma Shares Drop After Stem-Therapy Backing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxPQjVBeGZOQ2pTalZiY2tITDVlUWtVTC1YcnAzZ05Sd2Npclc3SUR1MGJMa2QtRFNKZFNVTlZzRzVQZXYzTTBHWTJKaHNRZTNNV01LcjAtTXNDWGxkUV9mQjA4NTBsOFZmR1NMRjNjMnVZeUR2aWRIbnI3bllpaGxWMDdkTFlOSWdMLWt2QlYyak1HUkUycHZaZEZJQXlSa1NDZXVERklzLVNxdHhBZVhXQk93VTBleGpXVmkxenRaNlppTzd6TXZLaDdNTThxcURPNG1kbTVlbDFUREs1UnpScmZfWHJGbFJvSWpkaWhrT2QtQlFuR3BvX1RGbmM5VnZNN3dr?oc=5","date":"2025-11-03","type":"regulatory","source":"PR Newswire","summary":"Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting - PR Newswire","headline":"Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting","sentiment":"neutral"}],"patents":[],"drugCount":11,"phaseCounts":{"phase_3":6,"phase_1":3,"phase_2":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}